Healthcare -
Biotechnology - NYSE - US
$ 7.58
-4.37 %
$ 444 M
Market Cap
-0.81
P/E
DNA - CASH FROM OPERATIONS
Cash from Operations DNA - Ginkgo Bioworks Holdings, Inc.
-320 M
LAST VALUE
-12.57%
2 YEAR CAGR
-48.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR